Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03530683
Title A Trial of TTI-622 in Patients With Advanced Relapsed or Refractory Lymphoma or Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Trillium Therapeutics Inc.
Indications

multiple myeloma

lymphoma

Therapies

TTI-622

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.